Gujarat FDCA approves licences of 189 hand sanitisers to meet growing demand amidst COVID-19 pandemic

The Gujarat FDCA has approved product licences of 189 hand sanitisers to tide over its growing demand due to the pandemic. The product licenses are mostly from small and medium Indian manufacturers which are complying with the provisions of cosmetic rules.

Adequate supply of sanitisers and antiretroviral (ARV) drugs like chloroquine phosphate has been maintained in the wake of pandemic.

According to an official associated with the development, “A state level committee has also been formed to oversee the consistent supply of ARV drugs, masks and sanitisers.”

The committee is headed by Gujarat Food and Drug Control Administration (FDCA) Commissioner Dr HG Koshia with members from the state industry department and state pollution control board.

Dr Koshia informed that, “This has to be followed religiously as the Central Government has notified Essential Commodities (EC) Order, 2020 to regulate the production, quality, distribution, logistics of masks (2ply and 3ply surgical masks, N95 masks) and hand sanitizers for COVID-19 management. We have made the provision of approving licenses for sanitisers production and distribution under the emergency use authorization for consistent supply.”
The EC order notification shall remain in force for a period up to June 30, 2020 from the date of its publication in the official gazette.

  • Related Posts

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    ‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

    ‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

    Governments have moved for Price Transparency in Hospitals to help patients cope with bills

    Governments have moved for Price Transparency in Hospitals to help patients cope with bills

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction